EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

RNA Analysis Enables Resolution and Reclassification of Reportedly Benign Synonymous Variants

Adina Fuchs, Inbar Kobal, Dov Popper, Shay Porat, Joshua I Rosenbloom, Mordechai Slae, Shira Yanovsky Dagan, Vardiella Meiner, Vered Molho-Pessach, Hagit Daum, Tamar Harel iD

Clinical Genetics · 2025

DOI: 10.1111/cge.14772 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Genetics, 2025. Verfasst von Adina Fuchs und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Hadassah Medical Center, Jerusalem, Israel. Hauptthemen laut MEDLINE: Amino Acyl-tRNA Synthetases, Silent Mutation, RNA. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Estate of David Weinstock.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synonymous variants can significantly impact protein levels and function, particularly through alterations in RNA processing. Consequently, variant classification must consider the broader impact on RNA splicing. We present three cases where synonymous variants were detected through exome sequencing. The variants in LARS1 and POLE were located at the last nucleotide of the exon (i.e., splice donor site), while the COL2A1 variant was located three nucleotides downstream of the splice acceptor site. Two variants were previously classified in ClinVar as “likely benign.” Segregation analysis confirmed segregation of the variants with the phenotype in available family members, and RNA studies revealed exon skipping in conserved regions of the protein, leading to reclassification of these variants as “likely pathogenic” and ultimately improving clinical management. These findings highlight the importance of incorporating RNA‐based testing to directly evaluate splicing effects and demonstrate the critical role of RNA analysis in the accurate interpretation of variants and their implications for diagnosis and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amino Acyl-tRNA SynthetasesSilent MutationRNAHumansRNA SplicingMaleFemaleExome SequencingExonsPedigreeRNA Splice Sites

Stichwörter der Autor:innen

COL2A1LARS1POLERNA analysisexome sequencingsynonymous variants

Substanzen

Amino Acyl-tRNA SynthetasesRNA Splice SitesRNA

Autor:innen und Institutionen

  • Department of Genetics, Hadassah Medical Center, Jerusalem, Israel.
  • Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Department of Dermatology, Hadassah Medical Center, Jerusalem, Israel.
  • Department of Obstetrics and Gynecology, Hadassah Medical Center, Jerusalem, Israel.
  • Pediatric Gastroenterology Department, Hadassah Medical Center, Jerusalem, Israel.

ORCID-Profile: Tamar Harel

Förderung

  • The Estate of David Weinstock

Zitieren

APA

Fuchs, A., Kobal, I., Popper, D., Porat, S., Rosenbloom, J. I., Slae, M., Yanovsky Dagan, S., Meiner, V., Molho-Pessach, V., Daum, H., & Harel, T. (2025). RNA Analysis Enables Resolution and Reclassification of Reportedly Benign Synonymous Variants. Clinical Genetics. https://doi.org/10.1111/cge.14772

Vancouver

Fuchs A, Kobal I, Popper D, Porat S, Rosenbloom JI, Slae M, et al. RNA Analysis Enables Resolution and Reclassification of Reportedly Benign Synonymous Variants. Clinical Genetics. 2025. doi:10.1111/cge.14772

BibTeX
@article{Fuchs2025,
  author = {Fuchs, Adina and Kobal, Inbar and Popper, Dov and Porat, Shay and Rosenbloom, Joshua I and Slae, Mordechai and Yanovsky Dagan, Shira and Meiner, Vardiella and Molho-Pessach, Vered and Daum, Hagit and Harel, Tamar},
  title = {RNA Analysis Enables Resolution and Reclassification of Reportedly Benign Synonymous Variants},
  journal = {Clinical Genetics},
  year = {2025},
  doi = {10.1111/cge.14772}
}
Kostenlos starten →